Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening

BACKGROUND: Breath volatile organic compounds (VOCs) have been reported as biomarkers of lung cancer, but it is not known if biomarkers identified in one group can identify disease in a separate independent cohort. Also, it is not known if combining breath biomarkers with chest CT has the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Michael, Bauer, Thomas L., Cataneo, Renee N., Lebauer, Cassie, Mundada, Mayur, Pass, Harvey I., Ramakrishna, Naren, Rom, William N., Vallières, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689411/
https://www.ncbi.nlm.nih.gov/pubmed/26698306
http://dx.doi.org/10.1371/journal.pone.0142484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689411/
https://www.ncbi.nlm.nih.gov/pubmed/26698306
http://dx.doi.org/10.1371/journal.pone.0142484

Ejemplares similares